Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoko Shigeta

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|March 4, 2025
Comparison of the Changes in Visceral Adipose Tissue After Lobectomy and Segmentectomy for Patients With Early-Stage Lung CancerTetsuya Isaka, Takuya Nagashima, Kota Washimi, et al.
BMC Cancer|November 5, 2023
Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter studyTetsuya Isaka, Hiroyuki Adachi, Kotaro Murakami, et al.
Clinical Lung Cancer|August 5, 2023
Effect of Surgical Treatment for N2-Positive c-stage III Non-Small Cell Lung Carcinoma in the "PACIFIC" EraHiroyuki Adachi, Hiroyuki Ito, Tetsuya Isaka, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 11, 2024
Mediastinal lymph node dissection in segmentectomy for peripheral c-stage IA (≤2 cm) non-small-cell lung cancerHiroyuki Adachi, Hiroyuki Ito, Takuya Nagashima, et al.
Frontiers in Oncology|January 22, 2026
A preoperative risk scoring system for survival prediction in clinical stage IB lung adenocarcinoma: a multicenter studyKotaro Murakami, Tetsuya Isaka, Takuya Nagashima, et al.
Translational Lung Cancer Research|August 13, 2025
Prognostic implications of MDM2 expression in surgically resected epidermal growth factor receptor mutant lung cancer with pathological lymph node metastasisTetsuya Isaka, Yohei Miyagi, Rika Kasajima, et al.
Translational Lung Cancer Research|July 11, 2026
Atypical type D extended sleeve resection after neoadjuvant chemoimmunotherapy in a 69-year-old man with locally advanced lung cancer and a tracheobronchial branching anomaly: a case reportChiaki Kanno, Takuya Nagashima, Yui Kaburaki, et al.
Translational Lung Cancer Research|November 29, 2023
Impact of RBM10 and PD-L1 expression on the prognosis of pathologic N1-N2 epidermal growth factor receptor mutant lung adenocarcinomaTetsuya Isaka, Yohei Miyagi, Tomoyuki Yokose, et al.
Thoracic Cancer|January 10, 2024
Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma"Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami, et al.
Frontiers in Oncology|September 13, 2023
Wedge resection vs. segmentectomy for lung cancer measuring ≤ 2 cm with consolidation tumor ratio > 0.25Tetsuya Isaka, Takuya Nagashima, Hiroyuki Adachi, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Cachexia, Sarcopenia and Muscle|March 4, 2025
Comparison of the Changes in Visceral Adipose Tissue After Lobectomy and Segmentectomy for Patients With Early-Stage Lung CancerTetsuya Isaka, Takuya Nagashima, Kota Washimi, et al.
BMC Cancer|November 5, 2023
Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter studyTetsuya Isaka, Hiroyuki Adachi, Kotaro Murakami, et al.
Clinical Lung Cancer|August 5, 2023
Effect of Surgical Treatment for N2-Positive c-stage III Non-Small Cell Lung Carcinoma in the "PACIFIC" EraHiroyuki Adachi, Hiroyuki Ito, Tetsuya Isaka, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 11, 2024
Mediastinal lymph node dissection in segmentectomy for peripheral c-stage IA (≤2 cm) non-small-cell lung cancerHiroyuki Adachi, Hiroyuki Ito, Takuya Nagashima, et al.
Frontiers in Oncology|January 22, 2026
A preoperative risk scoring system for survival prediction in clinical stage IB lung adenocarcinoma: a multicenter studyKotaro Murakami, Tetsuya Isaka, Takuya Nagashima, et al.
Translational Lung Cancer Research|August 13, 2025
Prognostic implications of MDM2 expression in surgically resected epidermal growth factor receptor mutant lung cancer with pathological lymph node metastasisTetsuya Isaka, Yohei Miyagi, Rika Kasajima, et al.
Translational Lung Cancer Research|July 11, 2026
Atypical type D extended sleeve resection after neoadjuvant chemoimmunotherapy in a 69-year-old man with locally advanced lung cancer and a tracheobronchial branching anomaly: a case reportChiaki Kanno, Takuya Nagashima, Yui Kaburaki, et al.
Translational Lung Cancer Research|November 29, 2023
Impact of RBM10 and PD-L1 expression on the prognosis of pathologic N1-N2 epidermal growth factor receptor mutant lung adenocarcinomaTetsuya Isaka, Yohei Miyagi, Tomoyuki Yokose, et al.
Thoracic Cancer|January 10, 2024
Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma"Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami, et al.
Frontiers in Oncology|September 13, 2023
Wedge resection vs. segmentectomy for lung cancer measuring ≤ 2 cm with consolidation tumor ratio > 0.25Tetsuya Isaka, Takuya Nagashima, Hiroyuki Adachi, et al.
Pageof 3